158 related articles for article (PubMed ID: 37306872)
1. SRPX2 promotes cancer cell proliferation and migration of papillary thyroid cancer.
Guo H; Liu R; Wu J; Li S; Yao W; Xu J; Zheng C; Lu Y; Zhang H
Clin Exp Med; 2023 Dec; 23(8):4825-4834. PubMed ID: 37306872
[TBL] [Abstract][Full Text] [Related]
2. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
[TBL] [Abstract][Full Text] [Related]
4. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
5. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
6. CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition.
Shu C; Wang S; Hu J; Xu M; Deng H; Maimaiti Y; Huang T
J Endocrinol Invest; 2023 Mar; 46(3):545-557. PubMed ID: 36306106
[TBL] [Abstract][Full Text] [Related]
7. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract][Full Text] [Related]
8. TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axis.
Wang L; Tan H; Huang Y; Guo M; Dong Y; Liu C; Zhao H; Liu Z
Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36222755
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
10. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R
Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of long non-coding RNA LINC00982 suppresses cell proliferation and tumor growth of papillary thyroid carcinoma through PI3K-ATK signaling pathway.
Xu D; Yu J; Zhuang S; Zhang S; Hong Z; Yuan C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262968
[TBL] [Abstract][Full Text] [Related]
12. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
13. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
[TBL] [Abstract][Full Text] [Related]
14. Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer.
Zhang HM; Li ZY; Dai ZT; Wang J; Li LW; Zong QB; Li JP; Zhang TC; Liao XH
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233293
[TBL] [Abstract][Full Text] [Related]
15. LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β.
Zhao WJ; Zhu LL; Yang WQ; Xu SJ; Chen J; Ding XF; Liang Y; Chen G
Cancer Sci; 2021 Apr; 112(4):1624-1632. PubMed ID: 33540491
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
Wu YC; Li SY; Jia YF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
Chen Y; Li Y; Gao H
Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
[TBL] [Abstract][Full Text] [Related]
19. High Expression of
Wang X; Bi Y; Liu X; Liu L; Hao M; Tian M; Shang J
Cancer Biother Radiopharm; 2022 May; 37(4):313-323. PubMed ID: 34388030
[No Abstract] [Full Text] [Related]
20. Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: Involvement of PI3K/AKT/mTOR signaling pathway.
Chen L; Zhuo D; Yuan H
Immunol Lett; 2022 Jun; 246():10-17. PubMed ID: 35447227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]